Where & When
Cicletanine (CCL) Timeline
1983
Diuretic effect, Prostacyclin
1st PubMed, Lancet
1986
Launch in France
Robust safety profile (1983 - current)
> 10,000 clinical-trials patients
2 million post-launch patient years; serious adverse events rare (< 1 / 100,000 patient-months)
1989
CCL vs. salt - sensitive hypertension (SSH)
1991
CCL vs. SSH & sympathetic overdrive
1995
CCL vs. sympathetic overdrive
1996
Japan
Basal generation of nitric oxide (NO) in the vascular wall of Dahl S rats
2001
Japan, France, US
Papers report nitric oxide, antioxidant activity; improved endothelial function
2009
BK channel activity
(Unpublished research) Relevant to vascular aging, Alzheimer’s; patent filed, 2023
2013
Endothelial-function activity confirmed: eNOS activation
US research confirms eNOS and PKG activation